| __timestamp | Geron Corporation | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 241751000 |
| Thursday, January 1, 2015 | 17831000 | 322292000 |
| Friday, January 1, 2016 | 18047000 | 344320000 |
| Sunday, January 1, 2017 | 11033000 | 374644000 |
| Monday, January 1, 2018 | 13432000 | 414604000 |
| Tuesday, January 1, 2019 | 52072000 | 466000000 |
| Wednesday, January 1, 2020 | 51488000 | 535000000 |
| Friday, January 1, 2021 | 85727000 | 643000000 |
| Saturday, January 1, 2022 | 95518000 | 833000000 |
| Sunday, January 1, 2023 | 125046000 | 899625000 |
| Monday, January 1, 2024 | 901530000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. has consistently outpaced Geron Corporation in R&D investments. From 2014 to 2023, Ionis increased its R&D spending by approximately 272%, reaching nearly $900 million in 2023. In contrast, Geron Corporation's R&D expenses grew by about 504% during the same period, peaking at $125 million in 2023. This significant difference highlights Ionis's aggressive strategy in pioneering new therapies, while Geron, though growing, remains more conservative in its expenditures. The data underscores the importance of R&D in driving biotech advancements and the varying strategies companies employ to maintain their competitive edge.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Genmab A/S and Geron Corporation
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation